TC
Tanakal Chandankumar
About Tanakal Chandankumar
Data last updated:
Tanakal Chandankumar is a Director at Sripad Business Solutions Private Limited (since 2023) and Designated Partner at Khadri Pharma Llp (since 2022). The companies operate in Paper. The largest current company by reported revenue is Sripad Business Solutions Private Limited at ₹2.31 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sripad Business Solutions Private Limited U46102TS2023PTC173208 | Director | 18 May 2023 | 2023 | ₹2.31 Cr (FY 2025) | Active |
| Khadri Pharma Llp ABZ-1378 | Designated Partner | 21 Nov 2022 | 2022 | Active |
Board colleagues of Tanakal Chandankumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vani Giri Sivaleela Tumuluru | 10029417 | Sripad Business Solutions Private Limited , Khadri Pharma Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tanakal Chandankumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tanakal Chandankumar
Tanakal Chandankumar currently holds 2 directorships: Sripad Business Solutions Private Limited (Director, since 18 May 2023, revenue ₹2.31 Cr (FY 2025)); Khadri Pharma Llp (Designated Partner, since 21 Nov 2022).
Tanakal Chandankumar was first appointed on 21 Nov 2022 as Designated Partner at Khadri Pharma Llp. The most recent appointment on record is 18 May 2023 at Sripad Business Solutions Private Limited.
The current boards of Tanakal Chandankumar's companies include Vani Giri Sivaleela Tumuluru (Sripad Business Solutions Private Limited).